1. This PowerPoint document contains the images that you requested.
Thank You
This PowerPoint document contains the images that you requested.
Copyright Notice
All materials on this Site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, or otherwise published without the prior written permission of Wolters Kluwer. You may not alter or remove any trademark, copyright or other notice.
However, provided that you maintain all copyright, trademark and other notices contained therein, you may download material (one machine readable copy and one print copy per page) for your personal, non-commercial use only. Please refer to this link for further information on how to
apply for permission for re-use
Any information posted to discussion forums (moderated and un-moderated) is for informational purposes only. We are not responsible for the information or the result of its practice.

2. Fig. 1.
Effects of Cancer Genetic Panel Testing on at-Risk Individuals
Frost, Anja S.; Toaff, Miriam; Biagi, Tara; Stark, Elizabeth; McHenry, Allison; Kaltman, Rebecca
Obstetrics & Gynecology131(6): , June 2018.
doi: /AOG
Schematic of genetic testing performed on study participants. *Patients with two mutations (n=4).Frost. Cancer Genetic Panel Testing in At-Risk Patients. Obstet Gynecol 2018.
Copyright © 2019 by The American College of Obstetricians and Gynecologists

3. Table 1.
Effects of Cancer Genetic Panel Testing on at-Risk Individuals
Frost, Anja S.; Toaff, Miriam; Biagi, Tara; Stark, Elizabeth; McHenry, Allison; Kaltman, Rebecca
Obstetrics & Gynecology131(6): , June 2018.
doi: /AOG
Breakdown of Panel Tests Performed
Copyright © 2019 by The American College of Obstetricians and Gynecologists

4. Table 2.
Effects of Cancer Genetic Panel Testing on at-Risk Individuals
Frost, Anja S.; Toaff, Miriam; Biagi, Tara; Stark, Elizabeth; McHenry, Allison; Kaltman, Rebecca
Obstetrics & Gynecology131(6): , June 2018.
doi: /AOG
Breakdown of Deleterious Mutations and Associated Cancer Risks
Copyright © 2019 by The American College of Obstetricians and Gynecologists

5. Fig. 2.
Effects of Cancer Genetic Panel Testing on at-Risk Individuals
Frost, Anja S.; Toaff, Miriam; Biagi, Tara; Stark, Elizabeth; McHenry, Allison; Kaltman, Rebecca
Obstetrics & Gynecology131(6): , June 2018.
doi: /AOG
Summary of mutations among panel-tested individuals (n=65 patients, n=69 mutations). Percentages are based on total number of mutations, not number of individuals, because four individuals had two mutations.Frost. Cancer Genetic Panel Testing in At-Risk Patients. Obstet Gynecol 2018.
Copyright © 2019 by The American College of Obstetricians and Gynecologists

6. Fig. 3.
Effects of Cancer Genetic Panel Testing on at-Risk Individuals
Frost, Anja S.; Toaff, Miriam; Biagi, Tara; Stark, Elizabeth; McHenry, Allison; Kaltman, Rebecca
Obstetrics & Gynecology131(6): , June 2018.
doi: /AOG
Clinical management recommendations after testing results. *Including breast, pelvic, and thyroid examinations. †Including mastectomy, salpingo-oophorectomy, hysterectomy, and colectomy. TVUS, transvaginal ultrasonography; REI, reproductive endocrinology; PSA, prostate-specific antigen; DRE, digital rectal examination; MRI, magnetic resonance imaging.Frost. Cancer Genetic Panel Testing in At-Risk Patients. Obstet Gynecol 2018.
Copyright © 2019 by The American College of Obstetricians and Gynecologists

7. Fig. 4.
Effects of Cancer Genetic Panel Testing on at-Risk Individuals
Frost, Anja S.; Toaff, Miriam; Biagi, Tara; Stark, Elizabeth; McHenry, Allison; Kaltman, Rebecca
Obstetrics & Gynecology131(6): , June 2018.
doi: /AOG
Distribution of variants of unknown significance.Frost. Cancer Genetic Panel Testing in At-Risk Patients. Obstet Gynecol 2018.
Copyright © 2019 by The American College of Obstetricians and Gynecologists